← Every company

Vertex Pharmaceuticals Inc SEC Filings

What Vertex Pharmaceuticals Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

VRTX overview →
Filings on file
119
since Oct 14, 2016
Warning signs
3
latest Sep 17, 2019
Last results
Aug 3, 2026
8-K item 2.02
Industry
Pharmaceutical Preparations
SIC 2834

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Sep 1, 2026
Executive or director change
8-K
Read ↗
May 13, 2026
Executive or director changeShareholder vote
8-K
Read ↗
Apr 29, 2026
Executive or director change
8-K
Read ↗
Aug 4, 2025
Executive or director changeResults announced
8-K
Read ↗
Feb 10, 2025
Executive or director changeResults announced
8-K
Read ↗
Dec 5, 2023
Executive or director change
8-K
Read ↗
Oct 5, 2023
Executive or director change
8-K
Read ↗
Apr 1, 2020
Executive or director change
8-K
Read ↗
Jul 25, 2019
Executive or director change
8-K
Read ↗
Jun 5, 2019
Executive or director changeShareholder vote
8-K
Read ↗
Apr 2, 2019
Executive or director change
8-K
Read ↗
Feb 22, 2019
Executive or director change
8-K
Read ↗
Jan 23, 2019
Executive or director change
8-K
Read ↗
Dec 17, 2018
Executive or director change
8-K
Read ↗
Sep 6, 2017
Executive or director change
8-K
Read ↗
Dec 2, 2016
Executive or director change
8-K
Read ↗

Source: Vertex Pharmaceuticals Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on VRTX

Related datasets